Clinical Trial Results
May, 18th, 2010
» Hundreds of Men Participated
In one of the first truly thorough clinical trials of a scientific product specifically designed to assist men seeking to overcome hair loss, the data returned by more than eight hundred participants had proved to be very promising indeed. Follixin is a once per day dietary supplement that has caused cessation of hair loss and visible hair growth in 94% of the men who participated in the first and second round of research study.Of the men who reported hair growth, 79% stated that they noticed hair growth 'equal to or greater than their goals' within the eight week trial period. The remaining 15% who reported gaining higher during the study expressed the results as 'significant' or 'exceeding expectations.' While a small number of men did not report significant gains during the short trial period, there were zero reported side effects of any kind and the men studied as part of the clinical trial unanimously agreed to continue use of Follixin after the study ended.
The men involved in the study represented a scientific cross section of ethnic, regional, age and socio-economic demographics. Data was collected in a double-blind manner with a proper control group and study group monitored daily for the test period of eight weeks. The results and hard data accumulated during the study have already lead researchers to fine-tune Follixin with a significant amount of optimism that it will eventually allow all men (and potentially women as well) to overcome hair loss regardless of the proximate cause of the decrease in follicle productivity.